Reports
Diagnosis to dignity: A vision for Alzheimer’s disease in Australia
Aged care Policy, research + analysisDiagnosis...
Bench to bedside: the promise of radioligand therapy
Radioligand therapy advancements are set to support the next phase in cancer care with their precision medicine approach
Breaking the cycle: Insights from the Inherited Cancers Australia community
Hereditary cancer cuts across generations, casting a shadow…
Closing the medicine gap: Improving First Nations peoples’ access to medicine
First Nations people experience…
Prioritising prevention: Addressing the burden of pneumococcal disease in Australia
As a leading health advisory firm, we recognise the urgency of addressing…
Changing lives: Improving access to blood cancer treatments in Australia
A trio of blood cancers are killing Australians. These cancers affect people of all ages and walks of life
Beyond Burnout: Supporting our General Practitioners
As the gateway to our health system, the demand and pressure on General Practitioners (GPs)…
Fighting Superbugs: Ensuring Australia is ready to combat the rise of drug resistant infections
Evohealth is proud to partner with the Australian Antimicrobial Resistance Network…
Cell and gene therapies: Rising to the challenge Scorecard 2023
Cell and Gene Therapies, or CGTs, are at the forefront of medical innovation. Unlike conventional medicines…
Time to Act: protecting our children from RSV
Respiratory syncytial virus (RSV) is the leading cause of hospitalisation for Australian infants and children under 5…
Connecting Nurses to Nurses
With our proximity to the equator, high proportion of fair skinned people and enjoyment of the great outdoors…
CAR T-cell therapy: Is Australia ready, willing and able?
Multiple myeloma is a devastating and incurable disease affecting thousands of Australians and their families…
Preparing Australia: Designing an Australian Centre for Disease Control (CDC)
For many Australians, the COVID-19 pandemic has been their defining experience of public health in action…
Shining a light: Radiotherapy cancer treatment in Australia
In Australia, there is one new cancer diagnosis every four minutes. Australia spends over $10 billion per year…
ASCVD in Taiwan: A public health priority
Cardiovascular disease (CVD) is a leading cause of morbidity and mortality globally – and yet, if identified early…
Cell and gene therapies: Rising to the challenge
Cell and gene therapies (CGTs) are changing the way that care is delivered to patients around the world…
Australia’s Cholesterol Heartache
Australia has become cholesterol complacent. This complacency is putting Australians living with cardiovascular disease (CVD) at risk…